Regulatory & Legal

The southeastern grocer maintains its dividend, a sign of stability as it continues rebuilding stores and its distribution network after Hurricane Helene.

With promising survival data and a pivotal Phase 3 trial underway, Imunon's localized immunotherapy could finally change the game for ovarian cancer.

US staffing firms added workers in Q3 2025, yet sales fell, revealing deep cost pressures on businesses and a complex outlook for the American economy.

Arizona State University just crossed $1 billion in research spending. This is the story of its disruptive rise and what it means for health, defense, and AI.

The premier investor summit returns with a global tour, new sessions on real estate, and a renewed focus on funding critical pediatric cancer research.

A new partnership aims to boost low colorectal cancer screening rates by combining trusted patient education with the promise of simpler blood-based tests.

Formerly Nature Wood Group, the forestry firm reports a surprise profit despite falling revenue after a complete change in ownership and leadership.

A successful demonstration of Revoltz's compact electric cargo vehicle to Israeli officials could signal a major shift in last-mile logistics.

WORK Medical's RMB 10M deal for its AI blood analyzer in East China signals a major push. Its unique 'interpretable AI' may be the key to success.

Backed by top industry awards and advanced threat research, Acronis solidifies its MSP-first strategy with a unified platform built for the AI era.

A new report from CYFIRMA shows its AI-powered DeCYFIR platform neutralized 2.1M risks, highlighting a major shift to preemptive cybersecurity.

He helped land a Bible on the moon, but his final years were spent in state custody as his historic legacy became trapped in a bitter legal battle.

A landmark journal issue introduces a new framework for facial rejuvenation, moving beyond outdated norms to embrace individualized, culturally sensitive care.

Branded Legacy just wiped out $1M in legacy debt. The move is part of a radical overhaul by new management aimed at rebuilding investor confidence.

StimLabs secures FDA clearance for Theracor, the first-ever umbilical cord sheet device, offering new hope for patients with hard-to-heal chronic wounds.

Finnish tech firm Bittium secures a landmark €120M licensing deal with Spain's Indra, boosting its finances and enabling sovereign defense technology.

Verisk terminates its $2.35B AccuLynx acquisition after FTC delays, triggering a $1.5B debt redemption and a potential legal battle with the spurned firm.

Cleveland expands its AI security robot program, citing reduced crime. But as other cities watch, questions of cost, privacy, and effectiveness emerge.

A critical labor dispute at Canada’s largest propane export terminal is over, but not before testing the resilience of a key global energy supply chain.

The cleantech firm hits key milestones in German and Italian energy projects while its unconventional portfolio expands into biotech and agritech.